L 5 - F&D DPI at Savaglobal, Pune

Open. Posted .

Dry Powder Inhalation formulation development spans product performance, device compatibility, process scale-up and technology transfer. The role is based in Pune.

Apply on Savaglobal's site for L 5 - F&D DPI

Applying opens the employer's page. Want jobs like this sent to you each morning? Open Elip.

Key facts
LocationPune, Maharashtra
Work modeOn-site
Experience4–6 years
PayNot stated by the employer
RoleLab & Pharma Scientist
Skills asked forDry Powder Inhalation formulation development, Pharmaceutics, Design of Experiments (DoE), Quality by Design (QbD), Aerodynamic Particle Size Distribution (APSD), Next Generation Impactor (NGI)
Posted19 Nov 2026

Elip's summary

Develops pharmaceutical formulations for a pharma and biotech services company. Plans and optimizes Dry Powder Inhalation products, applying Pharmaceutics, Design of Experiments (DoE), and Quality by Design (QbD) to powder, device, and aerosolization performance. Scales up processes and transfers formulations to manufacturing.

The job, in the employer's words

DPI Formulation Development: Independently plan and execute formulation development of Dry Powder Inhalation products, including single and combination products.

Preformulation Studies: Evaluate API and excipient characteristics such as particle size distribution, morphology, density, moisture content, flow properties, crystallinity, hygroscopicity, and compatibility relevant to DPI performance.

Excipient & Carrier Selection: Select and optimize suitable inhalation-grade carriers/excipients, including different grades of lactose and other applicable excipients, based on API properties and aerodynamic performance.

Particle Engineering Strategy: Evaluate API micronization/particle-engineering requirements and establish suitable particle-size and morphology targets to achieve desired aerosolization and lung deposition.

Blend Optimization: Develop and optimize DPI blending processes considering blending sequence, mixing time, speed, fill weight, segregation risk, content uniformity, and powder-flow characteristics.

Device–Formulation Compatibility: Evaluate compatibility of the formulation with capsule-, blister-, reservoir-, or multidose DPI devices and optimize formulation considering device resistance and aerosolization characteristics.

Product Performance Evaluation: Interpret critical DPI performance data including:

Delivered Dose Uniformity / Uniformity of Delivered DoseAerodynamic Particle Size Distribution (APSD)Fine Particle Dose (FPD)Fine Particle Fraction (FPF)MMAD and GSDEmitted DoseDevice retention/deposition

Reference Product Characterization: Conduct systematic characterization of reference/marketed products to understand formulation, device, physical characteristics, and critical performance attributes for generic product development.

QbD-Based Development: Define and evaluate QTPP, CQAs, CMAs, and CPPs and apply risk assessment, Design of Experiments (DoE), and scientific principles during formulation/process optimization.

Process Development & Scale-Up: Develop robust manufacturing processes covering dispensing, sieving, blending, filling into capsules/blisters, device assembly, and packaging, with consideration of scalability.

Stability Studies: Plan and evaluate stability studies and investigate the impact of temperature, humidity, moisture uptake, packaging, and physical changes on DPI product performance.

Technology Transfer: Execute formulation and process transfer from R&D to pilot/commercial manufacturing sites and provide technical support during scale-up, exhibit/registration, validation, and commercial batches.

Troubleshooting: Investigate formulation/process-related issues such as poor aerosolization, low FPF/FPD, high device retention, blend non-uniformity, segregation, variable delivered dose, and stability failures.

Documentation: Prepare and review development reports, BOM/MFR, product development reports, technology-transfer documents, protocols, risk assessments, QbD documents, and regulatory-support documentation.

Literature & Patent Evaluation: Conduct scientific literature, innovator-product, regulatory, and patent searches to support formulation strategy and identify potential development or patentability opportunities.

Coordinate with ADL for development and interpretation of DPI-specific analytical and performance testing, particularly APSD/NGI and delivered-dose studies.

Maintain accurate and contemporaneous Laboratory Notebooks (LNBs), experimental records, development data, and material accountability.

Support preparation of samples and documentation for stability, exhibit batches, BE/PK/clinical studies, regulatory submissions, and comparative in-vitro studies.

Soft Skills required:

Scientific & Analytical Thinking: Ability to correlate formulation variables, powder properties, device characteristics, and aerodynamic performance.

Problem-Solving: Strong troubleshooting capability for complex DPI formulation and process-development challenges.

Ownership & Execution: Ability to independently manage assigned development activities within defined project timelines.

Education & Qualification

Education: M. Pharm in Pharmaceutics

Experience: 4-6 years of relevant experience in Formulation & Development, preferably with significant hands-on exposure to DPI/OINDP product development.

About Savaglobal

Headquartered in Pune, founded in 2003.

People in Elip's index who work here
438
Typical time at Savaglobal
18 months
Typical career length so far
4.6 years

Largest teams

  • Operations74 people
  • Leadership56 people
  • Sales53 people
  • Quality Assurance35 people

Totals from public professional profiles in Elip's index; any group under ten people is left out.

All open jobs at Savaglobal

Similar open jobs

More jobs in Pune or all jobs on Elip

About this page

Elip lists jobs that employers publish on their own careers sites, never copies from job boards. This one comes from Savaglobal's listing on Keka, posted 19 Nov 2026. The summary is Elip's; the description is the employer's. When the job closes, this page says so.